Mergers & Acquisitions
Contract therapy company acquires operating assets of MeadowBrook Healthcare
Published in Drug Week, September 2nd, 2005
The purchase price was funded from a combination of $27.5 million in cash on hand and credit facilities, plus $9 million in subordinated notes. The company has concurrently entered into leases with respect to the four MeadowBrook facilities with SunTrust Equity Funding (STEF), a wholly owned subsidiary of SunTrust Bank. STEF acquired the real estate from MeadowBrook and affiliates in a separate transaction that closed concurrently with the company's asset purchase.
Based in Birmingham,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2005-09-02)
More Articles from Drug Week
- Breast Cancer
Beta-tubulin isotype alterations linked to docetaxel resistance - Drug Delivery
Data on ways to improve Fuzeon presented at meeting - Drug Development
Two additional sites initiated for phase II trial of ADH-1 - HIV/AIDS Therapy
Positive Thiovir data presented at IAS 2005 conference - Hepatocellular Carcinoma
Phase III study in hepatocellular carcinoma fails to achieve primary endpoint - Acromegaly
Acute octreotide test doesn't predict long-term Sandostatin LAR efficacy - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
